Click a keyword to view all the abstracts on this site tagged with that keyword.
- business
- business and rheumatoid arthritis (RA)
- C Reactive Protein
- C Reactive Protein and synovitis
- C-reactive protein (CRP)
- C-reactive protein (CRP) and Disease Activity
- C-reactive protein (CRP) and renal disease
- C-reactive protein (CRP) and rheumatoid arthritis (RA)
- C-reactive protein (CRP) and scleroderma
- C1q
- cadherin-11
- Cadherins
- calcinosis
- calcinosis and dermatomyositis
- Calcinosis and juvenile dermatomyositis
- Calcinosis and scleroderma
- Calcinosis and systemic sclerosis
- Calcinosis and treatment
- Calcitonin
- Calcium
- calcium and cardiovascular disease
- Calcium and denosumab
- Calcium and mesenchymal stem cells
- calcium and rheumatoid arthritis (RA)
- calcium and signal transduction
- Calcium pyrophosphate dihydrate (CPPD)
- Calcium pyrophosphate dihydrate (CPPD) and chondrocytes
- Calcium pyrophosphate dihydrate (CPPD) and diagnosis
- Calcium pyrophosphate dihydrate (CPPD) and pseudogout
- Calcium pyrophosphate dihydrate (CPPD) and rheumatoid arthritis (RA)
- Calcium pyrophosphate dihydrate (CPPD) and synovial fluid
- calcium pyrophosphate dihydrate (CPPD) and ultrasound
- Calgranulin
- canakinumab
- Canakinumab and caregivers
- canakinumab and corticosteroids
- canakinumab and familial Mediterranean fever
- canakinumab and fever
- canakinumab and interleukins (IL)
- canakinumab and juvenile idiopathic arthritis (JIA)
- canakinumab and monoclonal antibodies
- Canakinumab and safety
- canakinumab and treatment
- Cancer
- cancer and cancer treatments
- cancer and clinical practice
- Cancer and cutaneous lupus erythematosus
- cancer and histopathologic
- cancer and human papillomavirus (HPV)
- cancer and immunosuppressants
- Cancer and inflammatory arthritis
- cancer and lymphopenia
- cancer and malignancy
- Cancer and myositis
- cancer and nonsteroidal antiinflammatory drugs (NSAIDs)
- cancer and patient preferences
- Cancer and polymyositis/dermatomyositis (PM/DM)
- Cancer and psoriatic arthritis
- cancer and registry
- cancer and rheumatoid arthritis (RA)
- cancer and scleroderma
- cancer and systemic lupus erythematosus (SLE)
- Cancer treatments
- cancer treatments and immune response
- cancer treatments and inflammatory arthritis
- cancer treatments and morbidity and mortality
- cancer treatments and myositis
- Cancer treatments and osteoporosis
- cancer treatments and rheumatoid arthritis (RA)
- cancer treatments and rheumatologic disease
- Cancer treatments and rituximab
- cancer treatments and sarcoidosis
- cancer treatments and systemic sclerosis
- cannabinoid
- Capillaroscopy
- capillaroscopy and chemokines
- capillaroscopy and nailfold capillaroscopy
- capillaroscopy and scleroderma
- Capillaroscopy and systemic lupus erythematosus (SLE)
- capillaroscopy and systemic sclerosis
- capillary microscopy
- capillary microscopy and connective tissue diseases
- carboxypeptidase B and rheumatoid arthritis (RA)
- Cardiovascular and rheumatoid arthritis
- Cardiovascular disease
- cardiovascular disease and cholesterol
- cardiovascular disease and comorbidity
- Cardiovascular disease and cutaneous lupus erythematosus
- cardiovascular disease and depression
- cardiovascular disease and diabetes
- Cardiovascular disease and diffuse idiopathic skeletal hyperostosis (DISH)
- cardiovascular disease and endothelial cells
- cardiovascular disease and epidemiologic methods
- cardiovascular disease and exercise
- cardiovascular disease and extraarticular manifestations
- cardiovascular disease and fibrosis
- cardiovascular disease and genetic disorders
- cardiovascular disease and genetics
- Cardiovascular disease and giant cell arteritis
- Cardiovascular disease and glucocorticoids
- cardiovascular disease and gout
- cardiovascular disease and high risk
- Cardiovascular disease and hydroxychloroquine
- cardiovascular disease and immunoglobulin (IG)
- cardiovascular disease and inflammatory arthritis
- Cardiovascular disease and juvenile arthritis
- cardiovascular disease and juvenile dermatomyositis
- Cardiovascular disease and juvenile idiopathic arthritis (JIA)
- cardiovascular disease and juvenile SLE
- cardiovascular disease and lipids
- cardiovascular disease and longitudinal studies
- cardiovascular disease and meta-analysis
- cardiovascular disease and methotrexate (MTX)
- cardiovascular disease and morbidity and mortality
- cardiovascular disease and mycophenolate mofetil
- Cardiovascular disease and myositis
- cardiovascular disease and nonsteroidal antiinflammatory drugs (NSAIDs)
- Cardiovascular disease and nutrition
- cardiovascular disease and obesity
- Cardiovascular disease and osteoporosis
- cardiovascular disease and pediatric rheumatology
- cardiovascular disease and phenotypes
- cardiovascular disease and physical activity
- Cardiovascular disease and polymyalgia rheumatica
- cardiovascular disease and prevention
- cardiovascular disease and primary care
- Cardiovascular disease and psoriatic arthritis
- cardiovascular disease and race/ethnicity
- cardiovascular disease and reactive arthritis
- Cardiovascular disease and rheumatic disease
- cardiovascular disease and rheumatoid arthritis
- Cardiovascular disease and rheumatoid arthritis (RA)
- cardiovascular disease and risk
- cardiovascular disease and risk assessment
- cardiovascular disease and rituximab
- cardiovascular disease and statins
- cardiovascular disease and systemic lupus erythematosus (SLE)
- Cardiovascular disease and systemic sclerosis
- cardiovascular disease and systemic vasculitides
- cardiovascular disease and thrombosis
- Cardiovascular disease and tocilizumab
- cardiovascular disease and tofacitinib
- cardiovascular disease and uric acid
- Career
- career and fellowship programs
- Career and mentor
- caregivers
- caregivers and quality of life
- caregivers and rheumatic disease
- Carpal tunnel syndrome
- Carpal tunnel syndrome and corticosteroids
- carpal tunnel syndrome and sonography
- cartilage
- cartilage and chondrocytes
- cartilage and exercise
- cartilage and imaging techniques
- cartilage and magnetic resonance imaging (MRI)
- cartilage and methotrexate (MTX)
- cartilage and mouse model
- cartilage and osteoarthritis
- cartilage and pain
- cartilage and race/ethnicity
- cartilage and rheumatoid arthritis
- cartilage and rheumatoid arthritis (RA)
- Cartilage and stem cells
- cartilage and synovitis
- cartilage and transforming growth factor
- Case Report
- Case-based
- Castleman's disease
- Castleman's disease and IgG4 Related Disease
- Catecholamines
- catecholamines and cytokines
- catecholamines and regulatory cells
- Cathepsin
- cathepsin k inhibitor
- cathepsin k inhibitor and osteoarthritis
- CD T cells
- CD27
- CD70
- CD8 cells
- cell biology
- Cell biology and citrullination
- Cell biology and gout
- Cell biology and macrophage activation syndrome
- cell biology and methotrexate (MTX)
- cell biology and neutrophils
- Cell biology and osteoarthritis
- cell biology and regulatory cells
- Cell Migration
- Cell Migration and fibroblasts
- Cell Migration and psoriatic arthritis
- cell modulation
- cell modulation and systemic lupus erythematosus (SLE)
- Cell Signaling
- Cell Signaling and systemic lupus erythematosus (SLE)
- Cell therapy
- central nervous system involvement
- central nervous system involvement and osteoarthritis
- central nervous system involvement and psychological status